🔎 Trials Near Me

Akèy › Kansè pwostat › Florid › Orlando

Etid klinik pou Kansè pwostat nan Orlando, FL

17 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • Advent Health, Orlando
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 2
  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Ap rekriteFaz 3
  • AdventHealth, Orlando
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Ap rekriteFaz 2
  • Orlando VA Medical Center, Orlando, FL, Orlando
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Ap rekriteFaz 2
  • Orlando VA Medical Center, Orlando, FL, Orlando
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT04038502

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Ap rekrite
  • AdventHealth, Orlando
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06511141

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

Ap rekriteFaz 1/2
  • Research Site, Orlando
Laj 18 a 100 · Gason · Mizajou Sep 9, 2026 · NCT07529717

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Ap rekriteFaz 1
  • Sarah Cannon Research Institute @ Florida Cancer, Orlando
Laj 18 ak plis · Gason · Mizajou Sep 8, 2026 · NCT05800665

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Ap rekriteFaz 1
  • AdventHealth Orlando, Orlando
Laj 18 ak plis · Gason · Mizajou Feb 5, 2026 · NCT06631521

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialists & Research Institute, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jan 12, 2026 · NCT07181473

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site 137, Orlando
  • Research Site 118, Celebration · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05914116

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Adventhealth, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Nov 17, 2025 · NCT07231159

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #8, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 5, 2025 · NCT05932862

Exploring the Potential of Robotic Telesurgery in Remote Settings

Ap rekrite
  • AdventHealth, Celebration · 17 mi lwen
Laj 18 a 90 · Gason · Mizajou Aug 19, 2025 · NCT07130708

PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

Ap rekriteFaz 2
  • AdventHealth, Orlando
Laj 18 ak plis · Gason · Mizajou Oct 24, 2024 · NCT06617481

Etid Kansè pwostat nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.